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Abstract (words count=286) 1 
Background 2 
Little is known about the efficacy of personalized nutrition (PN) interventions for improving 3 
consumption of a Mediterranean diet (MD). 4 
Objective 5 
The objective was to evaluate the effect of a PN intervention on dietary changes associated 6 
with the MD. 7 
Design 8 
Participants (n=1607) were recruited into a 6-month, internet-based, PN randomized 9 
controlled trial (Food4Me) designed to evaluate the effect of PN on dietary change. 10 
Participants were randomized to receive conventional dietary advice (Control; L0) or PN 11 
advice based on current diet (L1), diet and phenotype (L2) or diet, phenotype and genotype 12 
(L3). Dietary intakes from food frequency questionnaires at baseline and 6 months were 13 
converted to a MD score. Linear regression compared participant characteristics between 14 
high (>5) and low (≤5) MD scores. Differences in MD scores between treatment arms at 15 
month 6 were evaluated using contrast analyses.  16 
Results 17 
At baseline, high MD scorers had 0.5 kg/m2 lower BMI (P=0.007) and 0.03 higher PAL 18 
(P=0.003) than low scorers. MD scores at month 6 were greater in individuals randomized to 19 
PN (L1, L2 and L3) compared with Control (PN: 5.20 ± 0.05 vs. Control: 5.48 ± 0.07 20 
respectively; P=0.002). There was no significant difference in MD scores at month 6 21 
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between PN advice based on L1 vs. L2 and L3. However, differences in MD scores at month 22 
6 were greater in L3 vs. L2 (L3: 5.63 ± 0.10 vs. L2: 5.38 ± 0.10 respectively; P=0.029). 23 
Conclusions 24 
Higher MD scores at baseline were associated with healthier lifestyles and lower adiposity. 25 
Following the intervention, MD scores were greater in individuals randomized to PN 26 
compared with the Control, with the addition of DNA-based dietary advice resulting in the 27 
largest differences in MD scores. Although differences were significant, their clinical 28 
relevance is modest.  29 
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INTRODUCTION 30 
The burden of non-communicable diseases and obesity has grown rapidly in the past 30 31 
years (1), with poor lifestyle choices, including unhealthy dietary patterns and increased 32 
sedentary behaviors, as the primary causes (2). Diets with high intakes of energy-dense and 33 
high-refined carbohydrate foods, are associated with obesity and type II diabetes (3, 4). In 34 
contrast, the Mediterranean diet (MD), characterized by low intakes of sugary snacks and 35 
beverages, and high intakes of fruit and vegetables has been consistently associated with a 36 
beneficial effect on health (5), including non-communicable diseases (6, 7) and obesity (8-37 
10). In addition, randomized controlled trials (RCTs) show that MD-based interventions 38 
reduce risk of cardiovascular disease in both primary and secondary prevention studies (11, 39 
12).  40 
Several approaches for scoring the MD have been developed (13, 14), including the 41 
PREDIMED 14-point score (15, 16). The latter identified 14 dietary components that best 42 
characterized the MD and demonstrated that higher MD scores were associated with up to 43 
30% lower incidence of cardiovascular events (15, 17). Based on such evidence, there is 44 
strong reason to believe that changing dietary intakes so that they align better with the MD 45 
would produce substantial public health benefit (18). However, achieving such changes may 46 
be challenging with current intervention strategies using “one size fits all” approaches, 47 
which have shown limited effect on population-level disease and obesity prevalence (1). 48 
Alternative strategies for facilitating improvements in diet and lifestyle include personalized 49 
nutrition (PN) approaches (19, 20). PN interventions are tailored to key characteristics of the 50 
individual participants, including current diet, phenotype and genotype. Although genetic-51 
based personalized interventions designed to change risk behaviors (e.g. smoking and diet) 52 
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have shown mixed results (21), recent genetic-based PN interventions have demonstrated 53 
encouraging changes in dietary behaviors (20, 22). Furthermore, internet-based dietary 54 
interventions offer the advantage of being scalable and more cost-effective than face-to-55 
face interventions (23). The Food4Me proof-of-principle (PoP) study was the first internet-56 
based study to demonstrate that PN advice was more effective in improving dietary intakes, 57 
including lowering intakes of red meat and improving diet quality when compared with 58 
conventional “one size fits all” population-based advice (24). Given that the MD is widely 59 
recognized as a healthy eating pattern, in this analysis we used the MD score an external 60 
(objective) reference to investigate whether internet-based PN advice improved the 61 
"healthfulness" of participants’ diets. 62 
The Food4Me PoP study was a 6-month, internet-based, PN intervention across 7 European 63 
countries designed to improve dietary intakes. The present paper aimed to evaluate the 64 
effect of this PN intervention by comparing differences in MD score at month 6 between 65 
treatment groups. 66 
 67 
METHODS  68 
Study design 69 
The Food4Me PoP study (25) was a 6-month, 4-arm, internet-based, randomized controlled 70 
trial (RCT) conducted across 7 European countries, designed to compare the effects of 71 
personalized dietary and physical activity advice with generalized advice in changing dietary 72 
and lifestyle behaviors (26). The intervention was intended to emulate a “real-life” internet-73 
based PN service, where all advice was delivered via the internet. Participants were recruited 74 
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to the intervention study via the Food4Me website (25) and were asked via email to complete 75 
online questionnaires and provide biological samples at 3 fixed time-points i.e. after baseline 76 
and 3 and 6 months. Online information about the study was available to participants 77 
including e.g. video clips describing how to make anthropometric measurements and to 78 
collect biological samples.  This design was complimented by an online interface through 79 
which participants could interact via email with the dietitians, nutritionists and researchers at 80 
each center during the 6 months intervention. The primary aims of the Food4Me study were 81 
to i) determine whether personalization of dietary advice assisted and/or motivated 82 
participants to choose a healthier diet in comparison with non-personalized, conventional 83 
healthy eating guidelines and ii) whether personalization based on individualized phenotypic 84 
or phenotypic and genotypic information was more effective in assisting and/or motivating 85 
study participants to make, and to sustain, appropriate healthy changes, than personalization 86 
based on diet alone. To address these aims, participants were randomized to one of four 87 
intervention arms using an urn randomization scheme (27) and received either non-88 
personalized, generalized dietary advice (Control; Level 0), or one of three levels of PN. To 89 
encourage dietary and lifestyle change, behavioral change techniques derived from work by 90 
Michie et al. on smoking cessation and dietary behavior change were used (28, 29). 91 
Participants were asked to complete online an food frequency questionnaire (FFQ), Baecke 92 
Physical Activity Questionnaire, wear accelerometers and provide self-measured 93 
anthropometric information, buccal swabs and dry blood spot cards (further details are 94 
provided below). 95 
 96 
Ethical approval and participant consent 97 
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1607 participants were randomized into the study and were recruited between August 2012 98 
and August 2013 from the following centers: University College Dublin (Ireland), Maastricht 99 
University (The Netherlands), University of Navarra (Spain), Harokopio University (Greece), 100 
University of Reading (United Kingdom, UK), National Food and Nutrition Institute (Poland) 101 
and Technical University of Munich (Germany). The Research Ethics Committees at each 102 
University or Research Centre delivering the intervention granted ethical approval for the 103 
study. The Food4Me trial was registered as a RCT (NCT01530139) at Clinicaltrials.gov. All 104 
participants expressing an interest in the study were asked to sign online consent forms at 105 
two stages in the screening process. These consent forms were automatically directed to the 106 
local study investigators to be counter-signed and archived (26). 107 
 108 
Eligibility criteria 109 
Based on sample size calculations we aimed to recruit a total of 1,540 study participants. As 110 
per the eligibility criteria, participants aged ≥18 years of age were included in the study. The 111 
following sets of exclusion criteria were applied: (i) pregnant or lactating; (ii) no or limited 112 
access to the Internet; (iii) following a prescribed diet for any reason, including weight loss, 113 
in the last 3 months; (iv) diabetes, coeliac disease, Crohn’s disease, or any metabolic disease 114 
or condition altering nutritional requirements such as thyroid disorders, allergies or food 115 
intolerances. 116 
 117 
Intervention arms 118 
Individuals were allocated to each treatment using an urn randomization scheme. Those 119 
randomized to Level 1 (L1) received personalized dietary advice based on current diet and 120 
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physical activity (PA) alone, Level 2 (L2) received personalized dietary advice based on 121 
dietary, PA and phenotypic data and Level 3 (L3) received personalized dietary advice based 122 
on dietary, PA, phenotypic and genotypic data. Personalized dietary feedback was based on 123 
how intakes of specific nutrients compared with recommended intakes, which was then 124 
translated into advice on changing intakes of food groups (fruits and vegetables, whole grain 125 
products, fish, dairy products and meat). Personalized phenotypic feedback utilized 126 
anthropometric measurements and nutrient- and metabolic-related biomarkers to derive 127 
personalized feedback and specific variants in five nutrient-responsive genes were used to 128 
provide personalized genotypic feedback. Personalized advice on PA was based on 129 
responses to the Baecke Questionnaire and accelerometer data. 130 
Participants randomized to the control group (L0) received dietary advice based on 131 
population-level healthy eating guidelines. This non-personalized dietary advice was derived 132 
from national dietary recommendations in each of the seven European countries and 133 
included generalized advice on the food groups listed above. In addition, these 134 
recommendations included a generic PA recommendation. Further details of the Food4Me 135 
PoP study are provided elsewhere (26). 136 
 137 
Personalized feedback report  138 
Participants randomized to L1, L2 and L3 received personalized feedback reports via email at 139 
baseline, month 3 and month 6 of the intervention. For those randomized to PN, algorithms 140 
were used to provide participants with 3 specific dietary goals according to the individual’s 141 
intakes of nutrients. For participants randomized to L2 and L3, the dietary advice was also 142 
based on phenotypic data (L2) and phenotypic plus genotypic data (L3). Reported intakes 143 
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were compared with recommended intakes and determined to be adequate, high or low. If 144 
intakes were too high or too low, contributing foods were identified and specific messages 145 
developed to advise change in intake of those foods. Estimations of healthy behaviors were 146 
explained using a three-color sliding scale: green representing “Good, no change 147 
recommended,” amber representing “Improvement recommended” and red representing 148 
“Improvement strongly recommended”. For the genotype-based information, risk was 149 
indicated using “Yes” or “No” according to whether the participant did, or did not, carry the 150 
higher risk variant for each of the 5 nutrient-related genes included in the study. 151 
Additionally, each report contained a personalized message from the dietitian/ nutritionist 152 
to the participant. Further details of the protocol are provided elsewhere (26).  153 
 154 
Participant characteristics and dietary intakes 155 
Following randomization, participants completed online questionnaires on socio-156 
demographic, health and anthropometric characteristics at baseline. Participants also 157 
completed an online FFQ to estimate usual dietary intake at baseline and at months 3 and 6 158 
of the intervention. This FFQ, which was developed and validated for the Food4Me Study 159 
(30, 31), included 157 food items consumed frequently in each of the 7 recruitment 160 
countries. Intakes of foods and nutrients were computed in real time using a food 161 
composition database based on McCance & Widdowson’s “The composition of foods” (32). 162 
Intakes were assessed using a standardized set of recommendations (26) for foods and food 163 
groups that were integrated and harmonized across 8 European countries (UK, Ireland, 164 
Germany, The Netherlands, Spain, Greece, Poland and Norway) (33-36). Further details are 165 
provided elsewhere (30).  166 
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Adherence to the MD was estimated based on the PREDIMED 14-point criteria (11, 16) 167 
(Supplemental Table 1). FFQs at baseline and month 6 were used to derive each of the 168 
following criteria: higher intake of olive oil than other culinary fat, higher intake of white 169 
meat than red meat, high intake of fruit (including natural fruit juice), vegetables, olive oil, 170 
legumes, nuts, fish, wine and tomato-based sauces and a limited intake of red and 171 
processed meats, fats and spreads, soft drinks and commercial bakery goods, sweets and 172 
pastries (11). Participants scored 1 point for each of the 14 criterion they met and 0 for each 173 
they did not meet; points were summed to create an overall MD score, ranging from 0-14 174 
(16). A dichotomous variable for MD score was created: “Low” (operationalized as a score 175 
≤5) and “High” (score >5) based on a median MD score of 5 at baseline.  176 
 177 
Anthropometric, socio-demographic and physical activity measures 178 
Body weight (kg), height (m) and waist circumference (WC; cm) were self-measured and 179 
self-reported. Participants were provided with information sheets and online video 180 
instructions in their own language on how to complete the measurements. Body mass index 181 
(BMI; kg/m2) was estimated from body weight and height. Self-reported measurements 182 
were validated in a sub-sample of the participants (n=140) and showed a high degree of 183 
reliability (37). Physical activity level (PAL, ratio between total energy expenditure and basal 184 
metabolic rate (BMR)), moderate and vigorous PA (MVPA), the percentage of individuals 185 
meeting PA recommendations (>150 min moderate PA or >75 min vigorous PA or an 186 
equivalent combination of moderate and vigorous PA per week (38)) and time spent in 187 
sedentary behaviors (SB) were estimated from triaxial accelerometers (TracmorD, Philips 188 
Consumer Lifestyle, The Netherlands).  189 
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Participants self-reported smoking habits and occupations. Occupations were grouped 190 
according to the European classifications of occupations and the respective salaries of these 191 
occupations. If the standard deviation of the salary for each occupation was >0.5 away from 192 
the mean European salary they were placed in Group 1, between 0.5 to -0.5 were placed 193 
into Group 2 and <-0.5 were placed into Group 3. The following groups and group names 194 
were generated: Group 1: “Professional and managerial”; Group 2: “Intermediate”; Group 3: 195 
“Routine and manual” (39, 40). Categories for “Students” and “Retired and unemployed” 196 
were added. 197 
 198 
Statistical analyses 199 
Data were analyzed using Stata (version 13; StataCorp, College Station, TX, USA) based on 200 
intention-to-treat (ITT) analysis of all individuals randomized into the intervention with 201 
baseline data (n=1480). Logistic and multiple linear regression were used to test for 202 
significant differences between groups at baseline for categorical and continuous variables 203 
respectively. Comparisons between low and high MD scores at baseline were adjusted for 204 
baseline age, sex and country. Physical activity outcomes were further adjusted for baseline 205 
wear time and season. To answer our primary research question (“What effect does a PN 206 
intervention have on dietary changes associated with the MD?”) we used a linear mixed 207 
model (LMM) with fixed effects for participants with time-point (baseline and follow-up), 208 
baseline age, sex and country as covariates. To remove treatment differences at baseline 209 
the parameter estimates (treatment arms) were specified at month 6 only. Contrast 210 
analyses to compare between treatment arms. The principal assessment of differences in 211 
MD scores used Contrast 1 comparing L0 (Control) with the mean of L1-L3 (mean of all three 212 
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personalized nutrition arms). Contrast 2, comparison of L1 with L2-L3, tested whether 213 
personalization based on phenotypic or phenotypic plus genotypic information differed 214 
from that based on dietary assessment only. Contrast 3, comparison of L2 with L3, tested 215 
whether the addition of genotypic information promoted changes which differed from 216 
those using phenotypic and dietary information only. Based on recommendations by White 217 
et al. (41) for the robust analysis of RCTs with missing outcome data, sensitivity analyses 218 
investigated the impact of running an ITT analysis based on the last observation carried 219 
forward (LOCF) method (n=1480) and a complete case (CC) analysis (n=1270). Additional 220 
sensitivity analyses adjusted for over- and under-reporters of total energy intake: under-221 
reporting was operationalized as energy intake less than BMR*1.1 (42), where BMR was 222 
calculated according to the Oxford equation (43) and over-reporting as more than 4500 223 
kcal/day (44). Furthermore, analyses in individuals who were randomized to L3 were 224 
stratified by carriage of the risk genotype for MTHFR, FTO, TCF7L2, APOE(e4) and FADS1 to 225 
identify genes that may be driving any added benefit of providing genetic information. 226 
Participants were coded “0” for no copies of the risk allele, “1” if they had one copy of the 227 
risk allele and “2” if they had two copies of the risk allele for each gene. A second variable 228 
was generated to indicate if an individual had no copies (“0”), one copy (“1”) or two copies 229 
(“2”) of the risk genotype for any of these genes. Results were deemed significant at P<0.05.  230 
 231 
RESULTS 232 
A total of 1607 participants were randomized into the intervention. Following dropouts 233 
immediately after randomization (n=127), 1480 participants provided dietary data at 234 
baseline and after 6 months intervention, outcome dietary data were available for 1270 235 
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participants (Figure 1). Information on how included participants compared with those who 236 
dropped out are summarized in Supplemental Table 2. 237 
 238 
Socio-demographic, anthropometric and health-related characteristics by MD score 239 
The average age of participants was 39.9 (13.0) years, 59% were female and 97% were 240 
Caucasian (Table 1). Participants with a high MD score at baseline were on average 1.5 years 241 
older than those with a low score (P=0.005). There were no differences in sex or ethnicity 242 
between high and low scorers. 39% of participants were in professional and managerial 243 
occupations, whereas 26 and 10% of participants were in intermediate and routine and 244 
manual occupations, respectively. No significant differences in occupations were observed 245 
between high and low MD scorers (Table 1).  246 
High MD scorers weighed 2.3 kg less (P=0.003), had 0.5 kg/m2 lower BMI (P=0.007) and 1.9 247 
cm lower WC (P<0.001) than low scorers (Table 1). High MD scorers spent less time in 248 
sedentary behaviors (P=0.005), had higher PAL (P=0.003) and MVPA (P<0.001) and met 249 
more PA recommendations (P=0.022) than low scorers (Table 1). More low MD scorers 250 
wanted to lose weight than high scorers (49 vs. 45%; P=0.041; Table 1), whereas more high 251 
scorers reported being on a restricted diet (9 vs. 6%; P=0.014; Table 1).  252 
On average, 6% fewer high MD scorers were on prescribed medication (P=0.004) than low 253 
scorers. No significant differences in total blood cholesterol or percentage of smokers were 254 
identified between MD scorers (Table 1). 255 
 256 
Dietary intakes by MD score 257 
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Although energy intakes did not differ, EI: BMR ratio was higher in high MD scorers than low 258 
MD scorers (1.72 ± 0.70 vs. 1.62 ± 0.63); P=0.012; Table 2). As expected, high MD scorers 259 
had lower percentage energy intakes from total fat (P<0.001) and SFA (P<0.001) and higher 260 
percentage energy intakes from MUFA (P=0.009) and PUFA (P<0.001) than low scorers 261 
(Table 2). Percentage energy intakes from protein and sugars were 1.2 and 1.7% higher in 262 
high MD scorers than low scorers (P<0.001), whereas percentage energy intakes from 263 
carbohydrates were 0.8% lower (P=0.042). Salt intake did not differ significantly between 264 
high and low MD scorers (Table 2). 265 
More high MD scorers met the recommendations for oily fish (36% more; P<0.001), red 266 
meat (7%; P=0.006) and fruit and vegetables (41%; P<0.001) than low scorers (Table 2). No 267 
significant differences in wholegrains or low-fat dairy products were observed between MD 268 
scorers (Table 2).  269 
 270 
Differences in MD scores following intervention 271 
After 6 months intervention, improvements in MD scores were greater in individuals 272 
randomized to PN (mean L1, L2 and L3) compared with Control (L0) (PN: 5.20 ± 0.05 vs. 273 
Control: 5.48 ± 0.07, respectively, P=0.002; Table 3). MD scores at month 6 in participants 274 
receiving PN advice based on current diet alone (L1) were not significantly different from 275 
those randomized to L2 and L3 (who received advice based on current diet + phenotype (L2) 276 
and diet + phenotype + genotype (L3); Table 3). However, MD scores at month 6 for 277 
participants receiving PN advice in L3 (diet + phenotype + genotype) were greater than in 278 
participants in L2 at month 6 (L3: 5.63 ± 0.10 vs. L2: 5.38 ± 0.10, respectively, P=0.029; Table 279 
 
 
18 
 
3). MD scores at month 3 between interventions arms were lower in those randomized to 280 
L2 compared with L3 (P=0.010; Supplemental Table 3). 281 
MD scores at month 6 when stratified by country were not significantly different for Control 282 
vs. PN (mean L1, L2 and L3). For the Netherlands only, MD scores was higher for L3 283 
participants than for L2 participants (P=0.013; Supplemental Table 4). When Mediterranean 284 
(Greece and Spain) and non-Mediterranean countries (the UK, Ireland, the Netherlands, 285 
Germany and Poland) were grouped, the effect of PN (mean L1, L2 and L3) vs. Control on 286 
MD scores at month 6 was significant in non-Mediterranean countries only (PN: 5.31 ± 0.09 287 
vs. Control: 5.02 ± 0.06; P=0.007; data not shown). 288 
 289 
Sensitivity analyses 290 
To determine whether our findings were robust to alternative analysis strategies, an ITT 291 
analysis based on LOCF and a CC analysis were also undertaken. Results showed that the 292 
pattern of significant findings were consistent across LMM, LOCF and CC analysis and that 293 
use of LMM produced the most conservative estimate of MD score at month 6 294 
(Supplemental Table 5).  295 
To understand the influence of genetic risk on MD score at month 6, analyses were stratified 296 
by non-risk and risk carriers for each of the 5 genes. For FTO and MTHFR genes, MD score at 297 
month 6 was higher in individuals randomized to PN compared with the Control in risk-298 
carriers only. The effect of PN on MD score at month 6 was similar for risk and non-risk 299 
carriers for APOE and TCF7L2 but was only significant for non-risk carriers of FADS1 300 
(Supplemental Table 6). As summarized in Supplemental Table 7, disclosure of genetic 301 
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information made little difference to MD score at month 6 for individuals randomized to PN 302 
compared with the Control, although differences were apparent between L2 and L3.  303 
Adjustment for under- and over-reporters did not change the pattern of results (data not 304 
shown). Stratifying analyses by carriage of a risk allele for any one of the 5 genes studied 305 
showed that in participants with two copies of a risk allele of any of the 5 genes, MD scores 306 
at month 6 were greater between participants randomized to PN (mean L1, L2 and L3) than 307 
those randomized to Control (5.69 ± 0.11 vs. 5.14 ± 0.08; P<0.001; data not shown). 308 
However, no significant differences in MD between PN and Control were observed in 309 
individuals carrying one or no copies of the risk alleles for any of the 5 genes and no 310 
significant differences between levels of PN were observed (data not shown).  311 
 312 
DISCUSSION 313 
Main findings 314 
The main findings from our secondary analysis in the Food4Me PoP study show that PN 315 
advice aiming to improve dietary intakes brought about changes in dietary behaviors that 316 
were in line with the MD. We observed that PN was more effective than generalized dietary 317 
advice (Control) in improving MD scores. Furthermore, the addition of genotypic 318 
information to PN advice improved MD scores compared with PN advice based on diet and 319 
phenotype alone. 320 
 321 
Comparison with other studies 322 
The aim of the Food4Me PoP study was to improve dietary intakes of food groups and 323 
nutrient (26) and findings from this intervention demonstrated that PN (mean L1, L2 and L3) 324 
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was more effective than “one size fits all” generalized dietary advice for lowering red meat 325 
(8.5%; P=0.046), salt intake (6.3%; P=0.008) and improving HEI (2.6%; P=0.010) (24). The 326 
present findings confirm that changes in dietary intakes associated with PN advice also 327 
result in significant improvements in dietary patterns, as estimated from the 14-point 328 
PREDIMED MD score. In contrast to the main analysis of the PN intervention, our secondary 329 
analysis of difference in MD scores between treatment arms suggest that the provision of 330 
genotype-based advice offers added benefit compared to PN advice based on diet and 331 
phenotype only. Although previous findings relating to whether the provision of genetic 332 
information improves dietary behaviors are encouraging (20, 22), further research is needed 333 
to determine if the apparent benefit is generalizable (e.g. applies to multiple types of 334 
genetic information and in different population groups) and results in sustained 335 
improvements in both diet and health outcomes. Moreover, the Food4Me PoP study was 336 
designed to improve overall diet, and not MD in particular, and thus the present findings 337 
should not be considered in isolation.  338 
Previous studies have evaluated the associations between adherence to the MD and health 339 
outcomes, including obesity, metabolic syndrome and type II diabetes. We confirmed 340 
findings from the PREDIMED study, showing that individuals with low MD adherence were 341 
more likely to be current smokers, have higher BMI and WC and lower PA (10, 18). The 342 
PREDIMED study found that low-economic status was associated with low-MD adherence 343 
and, although not statistically significant in the Food4Me study, we observed higher 344 
percentages of individuals in routine and manual occupations in the low MD score group 345 
compared with the high score group. As reported by Hu et al. (18), we also observed that 346 
older individuals were slightly more likely to have higher PREDIMED scores.  347 
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Our findings support the beneficial effect a MD on dietary quality, as evidenced by lower 348 
intakes of SFA and higher intakes of MUFA and PUFA and more individuals meeting food-349 
based dietary recommendations. In Food4Me, higher MD score was associated with higher 350 
intakes of sugar, although this may be due to higher fruit juice intake. 351 
To our knowledge, no previous studies have evaluated the effect of different levels of PN on 352 
difference in MD score. In the PREDIMED Study, 1,551 individuals were randomized to 353 
receive either leaflets providing generalized dietary advice based on American Heart 354 
Association guidelines (control) or personalized advice in one of two Mediterranean diet 355 
groups (45). Participants randomized to personalized advice received motivational 356 
interviews every three months to negotiate nutritional goals, as well as group educational 357 
sessions on a quarterly basis. Participants exposed to the MD-based intervention increased 358 
consumption of olive oil, nuts, vegetables, legumes and fruit and reduced consumption of 359 
meat and pastries, cakes and sweets, thus improving overall dietary patterns and supporting 360 
the use of PN in facilitating change towards a Mediterranean-style diet. Previous PN 361 
interventions have achieved improvements in sodium intake in individuals at higher 362 
genotypic-based risk (20), however, the Food4Me PoP study was the first to examine the 363 
effect of including genotype-based PN on overall patterns of healthy eating. Our study 364 
facilitated the comparison of PN intervention across 7 European countries, which showed 365 
that differences in MD scores between treatment arms were only evident in non-366 
Mediterranean countries. Baseline MD scores were low in Greece compared with Spain and 367 
changes following intervention were smaller compared with all other countries, which 368 
warrants further investigation.  369 
 370 
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Strengths and limitations 371 
The present study had a number of strengths. Our participants were drawn from 7 European 372 
countries, facilitating the comparison of MD between Mediterranean and non-373 
Mediterranean countries. Our estimation of MD was based on the PREDIMED 14-point 374 
score, which is a validated and widely-used MD score. We estimated changes in MD score in 375 
the largest study of PN in European adults to date. Furthermore, we confirmed the 376 
robustness of our findings by showing the same pattern of results when using three 377 
recommended analytical approaches for RCTs with missing outcome data (LMM, LOCR and 378 
CC analyses). 379 
A limitation of our study is that data were self-measured and self-reported via the internet, 380 
which may have introduced measurement error. Nonetheless, the accuracy of internet-381 
based, self-reported anthropometric have been confirmed in our study (37). Dietary intakes 382 
were estimated by a FFQ which is subject to misreporting error (46) but this was minimized 383 
by prior validation against a 4-day weighed food record (31). Small sample size limited our 384 
power to investigate the effect of individual genes in the present study. Additionally, 97% of 385 
our study participants were Caucasians and thus research in wider ethnicity groups is 386 
required to generalize our findings to other populations. Our sample is a self-selected group 387 
of individuals, who may be more health-conscious than the general population. However, 388 
characterization of the profile of our participants suggests that they would benefit from 389 
improved diet and PA (47). Furthermore, the Food4Me PoP study did not aim to change MD 390 
scores specifically, rather overall diet, which may indirectly have improved MD scores. 391 
 392 
Implications of findings 393 
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PN is a more effective approach for improving MD score than generalized dietary advice. A 394 
systematic review and meta-analysis of observational by Sofi et al. (2010) found that a 2-395 
point increase (10 point scale) in adherence to the MD was associated with a significant 396 
reduction of overall mortality [relative risk (RR) = 0.92; 95% CI: 0.90, 0.94], cardiovascular 397 
incidence or mortality (RR = 0.90; 95% CI: 0.87, 0.93) and cancer incidence or mortality (RR = 398 
0.94; 95% CI: 0.92, 0.96) (5). There is also accumulating evidence from intervention studies 399 
that randomization to the MD reduced CVD risk in both primary and secondary prevention 400 
studies (9, 12). The 0.5 unit advantage in PREDIMED score (14 point scale) for PN in the 401 
present study indicates that the potential health benefit may be relatively modest. The 402 
challenge for those developing future dietary interventions is to produce bigger, and 403 
sustained, dietary changes. This study suggests that providing individuals with more 404 
detailed, tailored recommendations based on a combination of their diet, phenotype, and 405 
genotype is advantageous. In addition, internet-based approaches offer significant 406 
opportunities for scaling up PN interventions in a cost effective manner. 407 
 408 
Conclusions 409 
Following a 6-month RCT, MD score were greater in individuals who received PN advice, 410 
compared with those who received non-personalized advice. Furthermore, improvements in 411 
MD score were greater in individuals who received PN based on diet, phenotype and 412 
genotype compared with advice based on diet and phenotype alone.  413 
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Table 1 Socio-demographic characteristics of participants according to Mediterranean diet (MD) score at 
baseline1 
 All Low MD score3 
 
High MD score4 P5 
n 1480 880 600  
MD score 5.12 ± 1.68 3.99 ± 1.02 6.77 ± 0.92 <0.001 
Age, years 39.9 ± 13.0 39.3 ± 12.9 40.8 ± 13.1 0.005 
Female, % 58.5 57.2 60.3 0.21 
Ethnicity, %     
Caucasian 96.8 97.3 96.0 0.42 
Occupation, %     
Professional and managerial 39.2 38.1 40.9 0.39 
Intermediate occupations 26.1 26.3 25.7 0.39 
Routine and manual 9.7 11.2 7.7 0.09 
Student 15.0 15.0 14.9 0.24 
Retired or Unemployed 10.0 9.4 10.9 0.70 
Anthropometrics     
Body weight, kg 74.8 ± 15.9 75.7 ± 15.8 73.4 ± 15.9 0.003 
BMI, kg/m2 25.5 ± 4.87 25.7 ± 4.79 25.2 ± 4.97 0.007 
Waist circumference, cm 85.7 ± 13.8 86.5 ± 13.8 84.6 ± 13.8 <0.001 
Overweight or obese, % 46.2 48.6 42.5 0.001 
Physical activity2     
PAL 1.73 ± 0.18 1.72 ± 0.17 1.75 ± 0.19 0.003 
MVPA, min/d 57.0 ± 45.0 54.0 ± 42.9 61.5 ± 47.7 <0.001 
Meet PA recommendations, % 77.3 75.7 79.6 0.022 
Sedentary behavior, min/d 746 ± 75.5 748 ± 75.3 742 ± 75.8 0.005 
Dietary conditions, %     
Want to lose weight 47.4 49.0 45.0 0.041 
Restricted diet 7.0 5.7 8.8 0.014 
Health and disease history     
Total blood cholesterol, mmol/L 4.56 ± 0.95 4.59 ± 0.97 4.52 ± 0.93 0.09 
Medication use, % 29.7 32.2 26.2 0.004 
Current smoker, % 11.8 11.8 11.7 0.56 
1, Values represent means and SD or percentages. MD, Mediterranean diet; BMI, body mass index; MVPA, 
Moderate and vigorous physical activity; PAL, physical activity level 
2, PA measures were available in 1285 participants only. 
3, Low Mediterranean diet (MD) score: ≤5 
4, High Mediterranean diet (MD) score: >5 
5, Multiple linear regression and logistic regression were used to test for significant differences between 
groups in continuous and categorical variables, respectively. Analyses were adjusted for age, sex and country. 
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Table 2 Dietary intakes of participants according to Mediterranean diet (MD) score at baseline1 
 All Low MD score2 
 
High MD score3 P4 
n 1480 880 600  
MD score 5.12 ± 1.68 3.99 ± 1.02 6.77 ± 0.92 <0.001 
Nutrient intake     
Total energy, kcal/d 2558 ± 1085 2519 ± 1073 2614 ± 1101 0.14 
EI:BMR ratio 1.66 ± 0.66 1.62 ± 0.63 1.72 ± 0.70 0.012 
Total fat, % energy 35.9 ± 5.91 36.4 ± 5.71 35.2 ± 6.12 <0.001 
SFA, % energy 14.1 ± 3.14 14.9 ± 3.16 13.0 ± 2.73 <0.001 
MUFA, % energy 13.7 ± 3.12 13.6 ± 2.85 13.9 ± 3.48 0.009 
PUFA, % energy 5.7 ± 1.44 5.6 ± 1.38 5.9 ± 1.52 <0.001 
Protein, % energy  17.1 ± 3.71 16.6 ± 3.49 17.8 ± 3.91 <0.001 
Carbohydrate, % energy 46.0 ± 7.60 46.3 ± 7.28 45.5 ± 8.03 0.042 
Sugars, % energy 21.1 ± 5.97 20.4 ± 5.70 22.1 ± 6.21 <0.001 
Dietary fiber, g/d 29.8 ± 14.6 26.8 ± 12.4 34.4 ± 16.4 <0.001 
Salt, g/d 7.37 ± 3.72 7.43 ± 3.84 7.28 ± 3.54 0.18 
Meeting dietary recommendations, %    
Oily fish 32.1 17.6 53.3 <0.001 
Wholegrains 74.2 73.9 74.7 0.37 
Red meat 50.5 47.8 54.5 0.006 
Fruit and vegetables 52.0 35.3 76.3 <0.001 
Low fat dairy 6.9 5.5 9.0 0.06 
1, Values represent means ± SD or percentages; MD, Mediterranean diet; EI, energy intake; BMI, body mass 
index; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 
2, Low Mediterranean diet score: ≤5 
3, High Mediterranean diet score: >5 
4, Multiple linear regression were used to test for significant differences between groups and were adjusted 
for age, sex and country.  
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Table 3 Effect of personalized nutrition intervention on Mediterranean diet (MD) score components at baseline and month 61 
 Control 
Mean (L0) 
Personalized nutrition 
Mean (L1, L2, L3) 
Personalized nutrition P 
L0 vs 
(L1+L2+L3) 
P 
L1  
vs  
(L2+L3) 
P 
L2  
vs  
L3 
L1 L2 L3 
n at baseline 360 1120 373 376 371    
MD score at baseline 5.17 ± 0.09 5.10 ± 0.05 5.16 ± 0.09 5.05 ± 0.09 5.09 ± 0.09 0.49 0.36 0.75 
MD score at month 6 5.20 ± 0.05 5.48 ± 0.07 5.43 ± 0.10 5.38 ± 0.10 5.63 ± 0.10 0.002 0.46 0.029 
Component scores at month 6        
Olive oil ratio 0.55 ± 0.02 0.60 ± 0.02 0.56 ± 0.03 0.61 ± 0.03 0.62 ± 0.03 0.08 0.022 0.73 
Olive oil intake 0.012 ± 0.003 0.002 ± 0.004 0.002 ± 0.005 0.005 ± 0.005 0.001 ± 0.005 0.039 0.99 0.31 
Vegetables 0.60 ± 0.02 0.62 ± 0.02 0.61 ± 0.03 0.63 ± 0.03 0.63 ± 0.03 0.47 0.41 0.91 
Fruit 0.58 ± 0.01 0.67 ± 0.02 0.67 ± 0.03 0.66 ± 0.02 0.69 ± 0.03 0.001 0.99 0.33 
Processed meat 0.90 ± 0.01 0.92 ± 0.01 0.92 ± 0.02 0.92 ± 0.02 0.93 ± 0.02 0.07 0.54 0.43 
Fat spreads 0.40 ± 0.02 0.45 ± 0.02 0.46 ± 0.03 0.43 ± 0.03 0.45 ± 0.03 0.09 0.54 0.52 
Fizzy drinks 0.98 ± 0.01 0.97 ± 0.01 0.98 ± 0.01 0.98 ± 0.01 0.97 ± 0.01 0.67 0.92 0.51 
Wine 0.07 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.94 0.81 0.53 
Fish 0.33 ± 0.01 0.36 ± 0.02 0.34 ± 0.03 0.33 ± 0.03 0.35 ± 0.03 0.79 0.97 0.52 
Legumes 0.15 ± 0.01 0.13 ± 0.02 0.11 ± 0.02 0.12 ± 0.02 0.15 ± 0.02 0.28 0.40 0.13 
Nuts 0.14 ± 0.01 0.16 ± 0.02 0.17 ± 0.02 0.13 ± 0.02 0.18 ± 0.02 0.39 0.53 0.07 
Sweets and pastries 0.19 ± 0.01 0.23 ± 0.02 0.24 ± 0.03 0.21 ± 0.03 0.21 ± 0.03 0.17 0.56 0.51 
White meat 0.29 ± 0.01 0.30 ± 0.02 0.31 ± 0.03 0.28 ± 0.03 0.30 ± 0.03 0.70 0.42 0.52 
Tomato sauce 0.011 ± 0.003 0.020 ± 0.005 0.017 ± 0.007 0.014 ± 0.007 0.030 ± 0.007 0.15 0.51 0.040 
1, Values represent adjusted means ± SE; contrast analyses were used to test for significant differences between groups; linear mixed models were adjusted for baseline 
age, sex and country. L0, Level 0 - Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on diet and 
phenotype; L3, Level 3 – personalized advice based on diet, phenotype and genotype. 
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FIGURE LEGENDS 
 
Figure 1 Consort diagram of participants randomized into the Food4Me Proof of Principle 
Study * Total number of participants reporting one or more exclusion criteria  
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Online Supplemental Material 
Supplemental Table 1 Scoring system for the PREDIMED-based Mediterranean diet (MD) score  
Point PREDIMED scoring system Serving size Food4Me MD scoring system 
1 Olive oil more than other culinary fat - More olive oil than other culinary fat (butter and other vegetable oils): 
operationalized as a ratio of olive oil to other culinary fat and a score of 
>0g 
2 Olive oil (≥4 tbsp/d) 11g Olive oil ( ≥44g) 
3 Vegetables (≥2 servings/d) 80g Vegetables (≥160g/d) 
4 Fresh fruits (including natural fruit juice; ≥3 servings/d) 80g for fresh or 
150ml for juice 
Fresh fruit and juice ( ≥240g/d); fruit juice was capped at 150g/d 
5 Red and processed meats (<1 serving/d) 150g Red and processed meat 
6 Spread fats (butter, margarine, cream; <1 serving/d) 12g Fats and spreads 
7 Soda drinks (<1 drink/d) 250ml Fizzy Soft Drinks E.g. Coca Cola / Lemonade 
8 Wine with meals (only for habitual drinkers; ≥7 glasses/wk) 175ml Wine (≥175ml/d) 
9 Legumes (≥3 servings/wk) 150g Legume ( ≥64.29g/d) 
10 Fish (especially fatty fish), seafood (≥3 servings/wk) 150g Fish and seafood ( ≥64.29g/d) 
11 Commercial bakery goods, sweets, and pastries§ (<3 servings/wk) 60g Sweets and snacks (all except crisps; <25.7g/d) 
12 Tree nuts and peanuts†(≥3 servings/wk) 30g Nuts And Seeds ( ≥12.86g/d) 
13 White meat Instead of red meat - More chicken (processed chicken, grilled chicken) than red meat (Beef, 
Pork, Burgers, Sausages): operationalized as a ratio of chicken to red meat 
and a score of >0g 
14 Sofrito (sauce made with tomato and onion, leek, or garlic, 
simmered with olive oil; ≥2 servings/wk) 
- Tomato sauces (≥90g) 
 
Online Supplemental Material 
Supplemental Table 2 Baseline characteristics of participants who completed the intervention and those who 
dropped out by month 61 
 Completers 
(n=1270) 
Dropouts 
(n=337) 
P2 
Mean SD Mean SD 
Age, years 40.8  13.0 34.8  12.3 <0.001 
Female, % 57.4 66.8 0.017 
Ethnicity    
Caucasian, % 96.9 96.1 0.83 
Occupation, %    
Professional and managerial 40.0 34.6 0.53 
Intermediate occupations 26.1 25.5 0.98 
Routine and manual 9.5 11.1 0.42 
Student 14.0 21.2 0.13 
Retired  3.0 2.4 0.39 
Unemployed  7.4 5.3 0.88 
Anthropometrics    
Body weight, kg 74.6  15.7 75.4  17.0 <0.001 
BMI, kg/m2 25.4  4.8 25.9  5.5 <0.001 
Waist circumference, cm 85.9  13.7 84.6  14.7 0.015 
Height, m 1.7  0.1 1.7  0.1 0.89 
Physical activity      
PAL 1.7  0.2 1.7  0.2 0.86 
Sedentary behaviour, min/d 747  75.2 732  77.1 0.31 
Medication use, %    
Prescribed medication 30.5 27.6 0.67 
Non-prescribed medication 10.3 7.7 0.32 
Health and disease    
Total cholesterol, mmol/L 4.6  1.0 4.3  0.9 0.06 
Current smoker, % 11.7 13.7 0.66 
Cancer, % 1.6 0.3 0.21 
High blood pressure, % 7.9 6.8 0.21 
Heart disease, % 1.4 1.2 0.61 
Diabetes, % 0.6 0.6 0.61 
Blood disorders, % 1.1 0.6 0.29 
1, Values represent means, SD or percentages; BMI, body mass index; PAL, Physical activity level 
2, Multiple linear regression and logistic regression were used to test for significant differences between 
groups in continuous and categorical variables, respectively. Analyses were adjusted for age, sex and country. 
Online Supplemental Material 
Supplemental Table 3 Effect of personalized nutrition intervention on Mediterranean diet (MD) score components at baseline and month 31  
 Control 
Mean (L0) 
Personalized nutrition 
Mean (L1, L2, L3) 
Personalized nutrition P 
L0 vs 
(L1+L2+L3) 
P 
L1  
vs  
(L2+L3) 
P 
L2  
vs  
L3 
L1 L2 L3 
n at baseline 360 1120 373 376 371    
MD score at baseline 5.17 ± 0.09 5.10 ± 0.05 5.16 ± 0.09 5.05 ± 0.09 5.09 ± 0.09 0.49 0.36 0.75 
MD score at month 3 5.26 ± 0.05 5.41 ± 0.07 5.42 ± 0.09 5.27 ± 0.09 5.54 ± 0.09 0.08 0.89 0.010 
Component scores at month 3        
Olive oil ratio 0.55 ± 0.02 0.62 ± 0.01 0.63 ± 0.02 0.58 ± 0.02 0.65 ± 0.02 0.008 0.66 0.035 
Olive oil intake 0.012 ± 0.003 0.006 ± 0.004 0.005 ± 0.006 0.002 ± 0.006 0.011 ± 0.006 0.29 0.77 0.20 
Vegetables 0.63 ± 0.02 0.60 ± 0.02 0.55 ± 0.03 0.60 ± 0.03 0.64 ± 0.03 0.18 0.02 0.24 
Fruit 0.60 ± 0.02 0.65 ± 0.02 0.65 ± 0.03 0.63 ± 0.03 0.66 ± 0.03 0.08 0.94 0.39 
Processed meat 0.90 ± 0.01 0.92 ± 0.01 0.91 ± 0.02 0.91 ± 0.02 0.93 ± 0.02 0.28 0.51 0.57 
Fat spreads 0.41 ± 0.02 0.44 ± 0.02 0.44 ± 0.03 0.44 ± 0.03 0.44 ± 0.03 0.20 0.95 0.98 
Fizzy drinks 0.98 ± 0.01 0.98 ± 0.01 0.98 ± 0.01 0.98 ± 0.01 0.97 ± 0.01 0.72 0.58 0.13 
Wine 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.86 0.60 0.85 
Fish 0.33 ± 0.01 0.33 ± 0.02 0.32 ± 0.03 0.32 ± 0.03 0.34 ± 0.03 0.87 0.75 0.55 
Legumes 0.14 ± 0.01 0.12 ± 0.02 0.13 ± 0.02 0.11 ± 0.02 0.13 ± 0.02 0.29 0.55 0.50 
Nuts 0.16 ± 0.01 0.14 ± 0.02 0.15 ± 0.02 0.11 ± 0.02 0.16 ± 0.02 0.26 0.55 0.08 
Sweets and pastries 0.17 ± 0.01 0.22 ± 0.02 0.26 ± 0.03 0.19 ± 0.02 0.20 ± 0.02 0.06 0.014 0.64 
White meat 0.29 ± 0.01 0.32 ± 0.02 0.33 ± 0.03 0.29 ± 0.03 0.34 ± 0.03 0.42 0.63 0.15 
Tomato sauce 0.097 ± 0.003 0.018 ± 0.004 0.020 ± 0.005 0.020 ± 0.005 0.013 ± 0.005 0.11 0.50 0.27 
1, Values represent adjusted means ± SE; contrast analyses were used to test for significant differences between groups; linear mixed models were adjusted for baseline 
age, sex and country. L0, Level 0 - Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on diet and 
phenotype; L3, Level 3 – personalized advice based on diet, phenotype and genotype. 
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Supplemental Table 4 Effect of personalized nutrition intervention on Mediterranean diet (MD) score at month 6 by country1  
 Control 
Mean (L0) 
Personalized nutrition 
Mean (L1, L2, L3) 
Personalized nutrition P 
L0 vs 
(L1+L2+L3)1 
P 
L1  
vs  
(L2+L3)1 
P 
L2  
vs  
L31 
L1 L2 L3 
UK (n=207) 5.60 5.77 5.47 5.83 5.99 0.53 0.12 0.62 
Ireland (n=217) 5.05 5.48 5.33 5.43 5.67 0.10 0.45 0.46 
The Netherlands (n=220) 5.24 5.45 5.38 5.18 5.79 0.29 0.62 0.013 
Germany (n=208) 4.68 5.06 5.13 5.00 5.05 0.12 0.67 0.87 
Spain (n=214) 6.06 6.41 6.37 6.15 6.71 0.19 0.81 0.08 
Greece (n=210) 5.25 5.38 5.70 5.28 5.19 0.58 0.06 0.73 
Poland (n=204) 4.47 4.78 4.57 4.84 4.96 0.21 0.21 0.70 
1, Values represent adjusted means ± SE; linear mixed models were used, with contrast analyses to test for significant differences between groups. Analyses were adjusted 
for baseline age and sex; L0, Level 0 - Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on diet and 
phenotype; L3, Level 3 – personalized advice based on diet, phenotype and genotype 
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Supplemental Table 5 Comparison of a liner mixed model (LMM), last observation carrier forward (LOCF) and a complete case analysis (CC) on the effect of personalized 
nutrition intervention on Mediterranean diet (MD) score components at baseline and month 61  
 Control 
Mean (L0) 
Personalized nutrition 
Mean (L1, L2, L3) 
Personalized nutrition P 
L0 vs 
(L1+L2+L3) 
P 
L1  
vs  
(L2+L3) 
P 
L2  
vs  
L3 
L1 L2 L3 
n at baseline 360 1120 373 376 371    
MD score at baseline 5.17 ± 0.09 5.10 ± 0.05 5.16 ± 0.09 5.05 ± 0.09 5.09 ± 0.09 0.49 0.36 0.75 
LMM (n=1480)         
MD score at month 6 5.20 ± 0.05 5.48 ± 0.07 5.43 ± 0.10 5.38 ± 0.10 5.63 ± 0.10 0.002 0.46 0.029 
LOCF (n=1480)         
MD score at month 6 5.26 ± 0.07 5.49 ± 0.04 5.44 ± 0.07 5.39 ± 0.07 5.64 ± 0.07 0.004 0.41 0.011 
CC (n=1270)         
MD score at month 6 5.31 ± 0.08 5.59 ± 0.05 5.54 ± 0.08 5.49 ± 0.08 5.73 ± 0.08 0.003 0.46 0.029 
1, Values represent adjusted means ± SE; contrast analyses were used to test for significant differences between groups; models were adjusted for baseline age, sex and 
country. L0, Level 0 - Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on diet and phenotype; L3, 
Level 3 – personalized advice based on diet, phenotype and genotype. 
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Supplemental Table 6 Effect of PN intervention on MD score at month 6 in participants stratified by risk vs non-risk genetic variants1 
 Control 
Mean (L0) 
Personalized 
nutrition 
Mean (L1, L2, 
L3) 
Personalized nutrition P 
L0  
vs 
(L1+L2+L3) 
P 
L1  
vs  
(L2+L3) 
P 
L2  
vs  
L3 
L1 L2 L3 
FTO (rs9939609)         
Non-risk (n=468) 5.18 ± 0.08 5.30 ± 0.12 5.38 ± 0.16 5.19 ± 0.16 5.32 ± 0.17 0.45 0.41 0.51 
Risk (n=1002) 5.21 ± 0.06 5.57 ± 0.09 5.46 ± 0.12 5.48 ± 0.12 5.74 ± 0.12 0.002 0.21 0.06 
MTHFR (rs1801133)         
Non-risk (n=661) 5.13 ± 0.08 5.34 ± 0.11 5.33 ± 0.14 5.24 ± 0.15 5.46 ± 0.14 0.13 0.88 0.19 
Risk (n=809) 5.59 ± 0.10 5.59 ± 0.10 5.52 ± 0.13 5.50 ± 0.13 5.75 ± 0.13 0.006 0.47 0.10 
ApoE (rs429358 & rs7412)         
Non-risk (n=1078) 5.15 ± 0.06 5.38 ± 0.08 5.38 ± 0.11 5.34 ± 0.11 5.43 ± 0.11 0.028 0.94 0.48 
Risk (n=386) 5.33 ± 0.10 5.72 ± 0.15 5.56 ± 0.19 5.47 ± 0.20 6.13 ± 0.20 0.040 0.24 0.006 
TCF7L2 (rs7903146)         
Non-risk (n=742) 5.20 ± 0.07 5.49 ± 0.10 5.52 ± 0.14 5.32 ± 0.14 5.64 ± 0.14 0.036 0.75 0.044 
Risk (n=725) 5.19 ± 0.07 5.49 ± 0.10 5.38 ± 0.14 5.49 ± 0.14 5.61 ± 0.13 0.016 0.23 0.45 
FADS1 (rs174546)         
Non-risk (n=839) 5.24 ± 0.07 5.62 ± 0.10 5.59 ± 0.13 5.54 ± 0.13 5.73 ± 0.13 0.019 0.75 0.21 
Risk (n=631) 5.14 ± 0.08 5.30 ± 0.11 5.25 ± 0.15 5.19 ± 0.15 5.47 ± 0.14 0.24 0.61 0.10 
1, Values represent adjusted means ± SE; linear mixed models were used, with contrast analyses to test for significant differences between groups. Analyses were adjusted 
for baseline age, sex and country; L0, Level 0 - Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on 
diet and phenotype; L3, Level 3 – personalized advice based on diet, phenotype and genotype. Risk carriers were defined as carrying one or two copies of the risk allele, 
while non-risk carriers carried no copies of the risk allele.  
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Supplemental Table 7 Effect of disclosing genetic information on MD score at month 6 participants classified as risk and non-risk carriers of genetic variants in L3 
 Control 
Mean (L0) 
L2 Disclosure of genetic 
information 
 
L0 
vs L3 risk 
 
L0  
vs  
L3 non-risk 
 
L2  
vs  
L3 risk 
 
L2  
vs  
L3 non-risk 
L3-risk 
carriers 
L3-non-risk 
carriers 
FTO, rs9939609 5.20 ± 0.05 5.39 ± 0.10 5.70 ± 0.10 5.41 ± 0.16 <0.001 0.022 0.012 0.88 
MTHFR, rs1801133 5.20 ± 0.05 5.39 ± 0.10 5.68 ± 0.12 5.55 ± 0.13 <0.001 0.016 0.030 0.26 
ApoE, rs429358 & rs7412 5.23 ± 0.05 5.41 ± 0.10 5.84 ± 0.17 5.53 ± 0.11 <0.001 0.004 0.016 0.16 
TCF7L2, rs7903146 5.18 ± 0.05 5.37 ± 0.10 5.68 ± 0.13 5.57 ± 0.13 <0.001 0.013 0.025 0.24 
FADS1, rs174546 5.19 ± 0.05 5.37 ± 0.10 5.61 ± 0.13 5.63 ± 0.11 0.003 0.002 0.10 0.09 
1, Values represent adjusted means ± SE; contrast analyses were used to test for significant differences between groups and were adjusted for baseline values; L0, Level 0 - 
Control, generalized advice; L1, Level 1 – personalized advice based on diet alone; L2, Level 2 – personalized advice based on diet and phenotype; L3, Level 3 – personalized 
advice based on diet, phenotype and genotype. Risk carriers were defined as carrying one or two copies of the risk allele, while non-risk carriers carried no copies of the 
risk allele.  
 
 
